HighMark Wealth Management LLC - RECRO PHARMA INC ownership

RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 47 filers reported holding RECRO PHARMA INC in Q1 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.2%.

Quarter-by-quarter ownership
HighMark Wealth Management LLC ownership history of RECRO PHARMA INC
ValueSharesWeighting
Q3 2023$227,458
-37.1%
484,985
+47.4%
0.19%
-30.5%
Q2 2023$361,887
+127.0%
328,988
+145.5%
0.27%
+119.4%
Q1 2023$159,446
+30.5%
133,988
+63.4%
0.12%
+34.8%
Q4 2022$122,16281,9880.09%
Other shareholders
RECRO PHARMA INC shareholders Q1 2023
NameSharesValueWeighting ↓
Samjo Capital LLC 8,039,100$3,770,3381.48%
First Light Asset Management, LLC 19,676,396$9,228,2300.88%
AWM Investment Company, Inc. 10,266,144$4,814,8220.71%
Caligan Partners LP 1,689,768$794,1910.36%
HighMark Wealth Management LLC 484,985$227,4580.19%
Nantahala Capital Management 1,250,000$586,2500.05%
Clear Harbor Asset Management, LLC 938,847$440,3190.05%
DRIEHAUS CAPITAL MANAGEMENT LLC 4,249,229$1,992,8880.03%
TITLEIST ASSET MANAGEMENT, LLC 210,148$98,5590.02%
ROYCE & ASSOCIATES LP 3,285,082$1,540,7030.02%
View complete list of RECRO PHARMA INC shareholders